S&P 500

5.302,45

1,06%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Rigel Pharmaceuticals Inc (RIGL)
Rigel Pharmaceuticals Inc (RIGL) Notícias

RIGL

Rigel Pharmaceuticals (RIGL)

Rigel Pharmaceuticals Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:RIGL

1 2 3 4 5 6 7 8 9 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
07/05/2024	17:16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
07/05/2024	17:01	PR Newswire (US)	Rigel Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
30/04/2024	09:05	PR Newswire (US)	Rigel Announces Conference Call and Webcast to Report First Quarter 2024 Financial Results and Business Update	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
10/04/2024	17:30	PR Newswire (US)	Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
04/04/2024	09:05	PR Newswire (US)	Rigel Announces Publication of Data on REZLIDHIA® (Olutasidenib) in Post-Venetoclax Patients with Mutant IDH1 AML in Leukemia & Lymphoma	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
12/03/2024	09:05	PR Newswire (US)	Rigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer, M.D. as Chief Medical Officer	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
05/03/2024	18:06	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
05/03/2024	18:01	PR Newswire (US)	Rigel Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
01/03/2024	21:16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
27/02/2024	10:05	PR Newswire (US)	Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2023 Financial Results and Business Update	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
22/02/2024	09:50	PR Newswire (US)	Rigel Pharmaceuticals Acquires U.S. Rights to GAVRETO®	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
14/02/2024	16:30	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
08/01/2024	10:05	PR Newswire (US)	Rigel Pharmaceuticals Provides Business Update	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
04/01/2024	10:05	PR Newswire (US)	Rigel Announces Collaboration with CONNECT to Conduct a Phase 2 Trial of Olutasidenib in Glioma	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
03/01/2024	10:05	PR Newswire (US)	Rigel to Present at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
08/12/2023	10:05	PR Newswire (US)	Rigel Pharmaceuticals and MD Anderson Announce Strategic Alliance to Advance REZLIDHIA® (Olutasidenib) in AML and Other Cancers	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
07/11/2023	18:05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
07/11/2023	18:01	PR Newswire (US)	Rigel Reports Third Quarter 2023 Financial Results and Provides Business Update	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
06/11/2023	10:05	PR Newswire (US)	Rigel to Present at the Jefferies London Healthcare Conference	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
02/11/2023	10:27	PR Newswire (US)	Rigel Announces Poster Presentations at the 65th American Society of Hematology Annual Meeting and Exposition	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
31/10/2023	09:05	PR Newswire (US)	Rigel Announces Conference Call and Webcast to Report Third Quarter 2023 Financial Results and Business Update	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
11/10/2023	09:05	PR Newswire (US)	Rigel Announces Presentation at the Upcoming IDWeek 2023	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
20/09/2023	09:05	PR Newswire (US)	Rigel to Present at the 2023 Cantor Global Healthcare Conference	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
30/08/2023	09:05	PR Newswire (US)	Rigel to Participate in Upcoming September Investor Conferences	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
01/08/2023	17:31	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
01/08/2023	17:01	PR Newswire (US)	Rigel Reports Second Quarter 2023 Financial Results and Provides Business Update	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
25/07/2023	09:00	PR Newswire (US)	Rigel Announces Conference Call and Webcast to Report Second Quarter 2023 Financial Results and Business Update	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
05/07/2023	17:30	PR Newswire (US)	Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
12/06/2023	09:22	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
07/06/2023	09:05	PR Newswire (US)	Rigel Announces Presentation of Data from Analysis of REZLIDHIA® (Olutasidenib) in Post-Venetoclax Patients with Mutant IDH1 AML	NASDAQ:RIGL	Rigel Pharmaceuticals Inc